Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells

Life Sciences

Volumn 62, Issue 20, 1998, Pages

  Moreland, Robert B ^a   Goldstein, Irwin ^a   Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cGMP; Corpus cavernosum smooth muscle cells; Penile erectile dysfunction; Phosphodiesterase type 5; Sildenafil (Viagra(TM))

Indexed keywords

BENZYLSULFONYL FLUORIDE; CYCLIC GMP; GUANYLATE CYCLASE; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; ZAPRINAST;

ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; PENIS ERECTION; SMOOTH MUSCLE FIBER;

EID: 0032502708     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00158-1     Document Type: Article

References (23)

1. 1. M. BOOLEL, M.J. ALLEN, S.A. BALLARD, S.G. GEPI-ATTEE, G.J. MUIRHEAD, A.M. NAYLOR, I.H. OSTERLOH and C. GINGELL. Int. J. Impotence Res. 8 47-52 (1996).
2. 2. A. TAHER, M. MAYER, C.G. STIEF, U. JONAS and W.G. FORSSMANN. World J. Urol. 15 32-35 (1997).
3. 3. S. LERNER, A. MELMAN and G.J. CHRIST. Urol. 149 1246-1255 (1993).
4. 4. K-E. ANDERSSON and G. WAGNER. Physiol. Rev. 75 191-236 (1995).
5. 5. J.A. LUGG, N.F. GONZALEZ-CADAVID and J. RAJFER. J. Androl. 16 2-4 (1995).
6. 6. A.L. BURNETT. J. Urol. 157 320-324 (1997).
7. 7. L.J. IGNARRO, P.A. BUSH, G.M. BUGA, K.S. WOOD, J.M. FUKITO and J. RAJFER. Biochem. Biophys. Res. Commun. 170 843-850 (1990).
8. 8. N. KIM, K. AZADZOI, I. GOLDSTEIN and I. SAENZ DE TEJADA. J. Clin. Inv. 88 112-118 (1991).
9. 9. F. TRIGO-ROCHA, G.L. HSU, C.F. DONATUCCI and T.F. LUE. J. Urol 149 872-877 (1993).
10. 10. T.M. LINCOLN and T.L. CORNWELL. FASEB J. 7: 328-338 (1993).
11. 11. H. ECKEL, C.G. STIEF, M.C. TRUSS, H-J. MAGERT, M. KRUHOEFFER, W.G. FORSSMANN and U. JONAS. J. Urol. 155 618A (Abstract 1230) (1996).
12. 12. R.B. MORELAND, A.M. TRAISH, M.A. MCMILLIN, B. SMITH, I. GOLDSTEIN and I. SAENZ DE TEJADA, J. Urol. 153 826-834 (1995).
13. 13. T.J. MARTINS, M.C. MUMBY and J.A. BEAVO. J. Biol. Chem. 257 1973-1979 (1982).
14. 14. M. DIXON. Biochem. J. 55 170-172 (1953).
15. 15. A.M. TRAISH, M.S. PALMER, I. GOLDSTEIN and R.B. MORELAND. Receptors 5 159-176 (1995).
16. 16. R. VIRAG. Int. J. Impotence. Res. 8 116 (Abstract A70) (1996).
17. 17. E. CHRISTIANSEN, M. HODGES, M. HOLLINGSHEAD, J. KIRPATRICK, S. DICKINSON and I. OSTERLOH. Int. J. Impotence Res. 8 147 (Abstract D99) (1996).
18. 18. W.W. DINSMORE, C.J. GINGEL, A. JARDIN, A.M. OLSSON, I. OSTERLOH, J. KIRPATRICK and M. CUDDIGAN. Int. J. Impotence. Res. 8 147 (Abstract D100) (1996).
19. 19. M. BOOLELL, P.K. YATES and M.B. WULFF. Int. J. Impotence Res. 8 147 (Abstract D101) (1996).
20. 20. F. BURNS, I.W. RODGERS and N.J. PYNE. Biochem. J. 283 487-491 (1992).
21. 21. J.A. BEAVO. Physiol. Rev. 75 725-748 (1995).
22. 22. J.B. POLSON and S.J. STRADA. Ann. Rev. Pharmacol. Toxicol. 36 403-427 (1996).
23. 23. C. SPARWASSER, P. DRESCHER, J.A. WILL and P.O. MADSEN. J. Urol. 152 2159-2163 (1994).